{"ModuleTitle": "Company Description", "CompanyName": "Exelixis, Inc.", "Symbol": "EXEL", "Address": "1851 HARBOR BAY PARKWAY, ALAMEDA, California, 94502, United States of America", "Phone": "6508377000", "Industry": "Biotechnology: Commercial Physical & Biological Resarch", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Exelixis, Inc. (Exelixis, we, our or us) is an oncology-focused biotechnology\r\ncompany that aims to accelerate the discovery, development and commercialization\r\nof new medicines for difficult-to-treat cancers.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2019%2f02%2f22%2f0000939767-19-000042.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Christopher J. Senner", "title": "Chief Financial & Accounting Officer, Executive VP"}, {"name": "Gisela M. Schwab", "title": "Chief Medical Officer & President-Medical Affairs"}, {"name": "Michael M. Morrissey", "title": "President, Chief Executive Officer & Director"}, {"name": "Peter Lamb", "title": "Chief Scientific Officer & EVP-Scientific Strategy"}], "Number_of_employees": [], "Subsidiaries": ["NO INFO"]}